Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 11, 2025 • 1:00 AM ET

Date/Time Source News Release
08/07/2025 04:05 PM EDT GlobeNewswire Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
07/31/2025 07:00 AM EDT GlobeNewswire Relmada Therapeutics to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
07/15/2025 08:00 AM EDT GlobeNewswire Relmada Therapeutics Appoints Renowned Urologic Oncologist, Yair Lotan, MD, to Chair the Clinical Advisory Board and Support Development of NDV-01
07/09/2025 08:00 AM EDT GlobeNewswire DIMERx Appoints Biotech Leader Sergio Traversa, PharmD, to Board of Directors
06/17/2025 07:00 AM EDT GlobeNewswire Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
05/12/2025 04:01 PM EDT GlobeNewswire Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
05/08/2025 07:30 AM EDT GlobeNewswire Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
04/28/2025 01:38 PM EDT GlobeNewswire Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025
04/27/2025 09:00 AM EDT GlobeNewswire UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
04/24/2025 08:00 AM EDT GlobeNewswire Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
Page

Additional News

As of August 11, 2025 • 1:00 AM ET

Date/Time Source News Release
08/08/2025 01:56 PM EDT SeekingAlpha Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances
08/08/2025 01:55 PM EDT SeekingAlpha Relmada Therapeutics, Inc. (RLMD) Q2 2025 Earnings Call Transcript
08/07/2025 05:03 PM EDT SeekingAlpha Relmada Therapeutics GAAP EPS of -$0.30
08/07/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, August 7th, 2025
08/07/2025 05:31 AM EDT US Earnings Reports Expected earnings - Relmada Therapeutics Inc.
05/12/2025 10:02 PM EDT SeekingAlpha Relmada Therapeutics, Inc. (RLMD) Q1 2025 Earnings Call Transcript
05/12/2025 04:29 PM EDT SeekingAlpha Relmada Therapeutics GAAP EPS of -$0.58 misses by $0.27
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Relmada Therapeutics Inc.
04/25/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: EV Battery Momentum and Weight Loss Financing Lead to Mixed Performance Amidst Market Rally Cooldown
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.